A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia
Clinical trial NCT01685892 · COMPLETED
Trial details
- NCT number
- NCT01685892
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-29
- Primary completion
- 2018-05-21
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.